STOCKS TELEGRAPH

Tag: Morning News

  • Profitable Stocks to Trade Today for  Exponential Gains

    Profitable Stocks to Trade Today for  Exponential Gains

    Aptinyx Inc [NASDAQ: APTX]

    Clinical-stage biopharmaceutical company Aptinyx Inc., reported today of its positive results from the second phase of its novel NVDA receptor module, NYX-783 clinical trial.

    The study involved 153 patients suffering from post-traumatic-stress disorder (PTSD). In this study, NYX-783 showed statistically and clinically significant efficacy results of this treatment. Following these results, Aptinyx expects to kick-start a serious study in 2021. PTSD is one of the most difficult psychiatric conditions to treat due to multiple debilitating symptoms.

    Murray Stein, the Vice-Chair for Clinical Research in Psychiatry at the University of California San Diego says that it is encouraging to get such positive results and considering the short duration that NYX-783 takes to cure this disorder.

    Uxin Ltd [NASDAQ: UXIN]

    Uxin Limited, an international online Chinese company dealing with used cars recently announced that it has entered into two definitive agreements with two investors that will see the company raise US$25,000,000.

    In these agreements, Uxin plans to issue an aggregate of 84,692,839 Class A ordinary shares through private placements that will occur in October 2020. Additionally, Uxin also entered into a letter agreement with affiliates of TPG, 58.com and Warburg Pincus to alter the conversion of price of the convertible notes in an aggregate total of about US$230 million.

    Based on this letter in two years after the agreement, if the Company issues or sells any equity securities less than the conversion price, the strategic investors will have a right to convert all or a part of their convertible notes at a price that is equal to New Issue Price.

    Iterum Therapeutics Plc  [NASDAQ: ITRM]

    Iterum Therapeutics plc announced today that it will present its data at the Infectious Disease Society of America IDWeek that will take place virtually as from October 21, 2020.

    The data presentations will include results for SURE-2, that will show the effects in complicated urinary tract infections (cUTI) and oral abstract presentation that are results from SURE-1 in uncomplicated urinary tract infections..

    This data shows that oral sulopenem was statistically stronger than oral ciprofloxacin to treat patients with uncomplicated urinary tract infections. Iterum Therapeutics is a clinical-stage pharmaceutical institution that is focussed on developing oral and IV antibiotics for the treatment and management of infections caused by drug resistant pathogens in both hospital and home settings.

  • Stocks to Watch Today as Major Indices Drop

    Stocks to Watch Today as Major Indices Drop

    Colour Star Technology [NASDAQ: CSCW]

    Colour Star Technology [NASDAQ: CSCW] is a top performer this morning and is up by over 51% pre-market. This follows the company’s announcement that it will be launching a series of interactive events that will be aired live. These events will feature the company’s growing group of Star Teachers. It is in line with the firm’s celebration of upgrading its Colour World App. The first event will feature the establishment’s “Star Teacher” Julaiti, a 20-year-old musician who has grown in popularity following his top hit that attained a top 15 finish on “Super Boy 2017”. This event will present users of the Colour World App with a rare opportunity to interact with this famed musician.

    Altimmune, Inc [NASDAQ: ALT]

    Altimmune, Inc [NASDAQ: ALT] is in the green pre-market too. In its bid to manufacture a COVID-19 vaccine, announced yesterday the launch of its pre-clinical trials of its single-dose, intranasal COVID-19 vaccine called AdCOVID. This vaccine is based on the firm’s adenovirus-based intranasal platform the expresses the receptor-binding domain (RBD) of the protein found in SARS-CoV-2. RBD is important as a preventative measure that will keep vaccinated individuals with a history of prior infection from spreading the virus. The virus has an advantage over many other available vaccines thanks to its single-dose effectiveness, intranasal administration, broad immune activation, and the ease with which it can be stored and transported. Altimmune worked in collaboration with the University of Alabama expanding on its earlier preclinical data. This is a big deal and could see the stock rally all through the day.

    Auris Medical Holding Ltd [NASDAQ: EARS]

    Auris Medical Holding Ltd [NASDAQ: EARS] is in the green pre-market and is up by over 88% without any major news. The company that has a lead product candidate for acute vertigo had positive progress last month. The rally also comes more than a month after the company announced its business update financial results for the fiscal year ended 2020. Auris Medical’s founder, CEO, and Chairman said that they have had significant milestones with their intranasal betahistine program. They have reported positive results in the last two clinical trials. The two trials AM-125 and AM-201 showed therapeutic potential in the development of a drug-free nasal spray against airborne diseases. There is a strong need for protection against airborne diseases as shown by the ongoing COVID-19 pandemic.  The biopharmaceutical company hopes to develop such protection with its going trials.

     

  • Stocks to Watch as Chinese Data Drives Market Optimism

    Stocks to Watch as Chinese Data Drives Market Optimism

    U.S markets are headed for a good start to the day. They are already in the green pre-market and are in line with European stocks that have been trading in positive territory for the better part of the day. This follows news that the Chinese economy was getting stronger despite the COVID-19 pandemic. Stocks in China, and across the world are rallying after news that the Chinese government is looking into ways for institutional investors to draw in more funds in the foreseeable future. Data from China also shows that the country’s tourism sector has rebound with the country in full control over the COVID-19 pandemic. The effect that Chinese data has on the markets has a lot to do with the impact of the Chinese economy on the world economy. China has the second-largest economy in the world, and it exports lots of products to the world. Therefore, when China shows signs of growth, it points to resilience in the global economy, and it inspires optimism in the U.S and across the world. Besides data from China, U.S markets are still riding on the momentum that built up last week over a possible stimulus package. There are hopes that such a deal could be arrived at before Christmas and help uplift businesses, and basically get the economy rolling again. Increased hopes of a COVID-19 vaccine coming out any time soon is also likely to keep U.S markets going strong in the short-term. Under current circumstances, there are several stocks that look set to rally all through the day, going by their pre-market price action. Some of the big gainers pre-market that are likely to keep gaining all through the day are as below:

    Medley Management Inc [NYSE: MDLY]
    Medley Management Inc is a top performer pre-market and is up by over 200%. This follows news late last week that the company had its MCC Senior Loan Strategy JV portfolio. The sale was made to a fund managed by Golub Capital LLC for $156.4 million.

    RedBall Acquisition Corp [NYSE: RBAC-UN]
    RedBall Acquisition Corp is a top performer this morning and is up by over 10% at the time of writing. This follows the company’s announcement a week ago that it had started the separate trading of class A shares and warrants. This has created lots of excitement around the stock since then.

    Borqs Technologies Inc [NASDAQ: BRQS]
    Borqs Technologies Inc in the green pre-market and is up by over 8%. This comes days after the company reported its full-year results, and also announced that it had regained compliance to the NASDAQ listing rules. Stocks to Watch as Chinese Data Drives Market Optimism

  • Stocks to Watch as Markets Rally to 5-weeks High on Stimulus Hopes

    Stocks to Watch as Markets Rally to 5-weeks High on Stimulus Hopes

    The equity markets are up this morning. The NASDAQ, the S&P 500, and the Dow are all at their highest levels in close to a month. This comes after renewed hopes of a stimulus deal between democrats and republicans to save the economy. The deal if agreed upon is likely to be actualized before Election Day.  The optimism around it has seen the markets rally despite worsening jobless numbers.

    The latest unemployment data shows that last week, the number of people filing for unemployment insurance benefits pushed through the 840k mark. Though the total numbers dipped from the 11 million high that was recorded in March at the height of the lockdowns, it still points to a relatively depressed economy. Optimism around an agreement increased after Nancy Pelosi met and discussed the package yesterday with Treasury Secretary Steven Mnuchin. Reports about the meeting state that Mnuchin stated that the President was much interested in reaching a deal.

    Analysts are looking forward to a deal, with Jeffrey Buchbinder of LPL Financial Equity stating that a deal would deliver a surprise to the markets in October. With optimism on the rise, there are stocks that are doing exceptionally well pre-market. Some of the biggest stock gainers this morning that could close the day in gains are as below:

    Medigus Ltd [NASDAQ: MDGS]

    Medigus is a top performer pre-market and is up by over 55% at the time of writing. This follows news that the company had entered into an e-commerce brand marketing on Amazon marketplace.  The company stated that it had entered into a definitive agreement to buy a majority stake in Smart Repair Pro Inc and Purex Inc.  These are data-driven eCommerce companies that run on the Amazon Marketplace. Under the deal, Medigus Ltd will have 50.01% in the two companies and will be paid for in cash and shares. Commenting on the development, Medigus CEO, Liron Carmel stated that the company was committed to growing its footprint in the eCommerce space.

    Pacific Drilling S.A. [NYSE: PACD]

    Pacific Drilling S.A. is another big gainer this morning and is up by over 15% pre-market. This is largely momentum-driven and follows the company’s announcement of strong Q2 results 4 days ago. The company reported that it had sales of $38.91 million and that earnings were up by 80.31% in the quarter.

    Sanchez Midstream Partners LP [NYSE: SNMP]

    Sanchez Midstream Partners LP is a top performer this afternoon and is up by over 200% this morning. This is largely a price action move and is backed by the improved sentiment in the overall market.

     

  • Stocks to Watch as Hopes of a Stimulus Package Uplifts Markets

    Stocks to Watch as Hopes of a Stimulus Package Uplifts Markets

    Orbital Energy Group Inc [NASDAQ: OEG]

    Orbital Energy Group, Inc is a top gainer in pre-market trading. Though it has no major news, the stock is riding on strong quarterly results a few weeks ago. The financial report shows the company’s financial performance in the just-ended financial year, capturing the effects of the ongoing global pandemic of COVID-19. The company recorded a gross profit of $1 million despite the tumultuous pandemic period but had an operating loss of $7.2 million as compared with the previous year where they recorded an operating loss of $3.2 million. This year’s operating loss, however, is also partly due to the acquisition of Reach Construction Group. Jim O’Neil, the CEO, and vice-chairman of the company noted their continued transformation in the energy sector despite the challenges most corporations have been facing this year.

    Rockwell Medical Inc [NASDAQ: RMTI]

    Rockwell Medical Inc is another stock riding on the strength of recent news that could impact on its bottom-line. A while back, Rockwell Medical, Inc., a company in the biopharmaceutical industry with a focus on treating iron deficiency and anaemia management, announced today that it has hired Russel L. Skitbusted, M.B.A., as the company’s Chief Business Officer, Chief Financial Officer, and Executive Vice President. Russel’s responsibilities will include financial operations, business development, and investor relations. The President and Chief Executive Officer of Rockwell Medical, Russell Ellison, M.D., M.Sc., said that the company was pleased to hire Russell in his capacity considering his wealth of experience in other publicly traded biotechnology companies in similar capacities. He further said that Russell will be a great addition to the attainment of the Rockwell Medical going forward.

    ALJ Regional Holdings, Inc [NASDAQ: ALJJ]

    ALJ Regional Holdings Inc., today announced its financial updates of the fiscal fourth quarter of the year ended September 30, 2020. According to the company’s Chief Executive Officer, Jess Ravich, the company showed continued improvement in the fiscal fourth quarter of 2020. As a result of high trade volumes for books and other trade components, the Phoenix results were much stronger than expected. Following these results, he projects that the corporation could record higher results than the forecasted adjusting to EBITDA. As of the moment, the forecasting adjusted to EBITDA is in the range of $8 to $9 million in the last three months ended September as compared to $5.3 to $6 million in the corporation’s third quarter. This is likely to keep the stock gaining in the near-term.

  • Top Stocks to Watch as Equity Markets Rebound

    Top Stocks to Watch as Equity Markets Rebound

    Rave Restaurant Group Inc [NASDAQ: RAVE]

    Rave Restaurant Group Inc is up by over 300% this morning and gaining.  This follows the company’s announcement that had just hired two new seasoned executives to spur up its development. The new executives are Darren Webb and Dion Firooznia.

    Webb will be the new director of development for Rave as well as supporting both Pie Five Pizza and Pizza Inn, while Firooznia will be the Pizza Inn franchise business consultant. These two individuals bring in a range of experiences that will see Rave develop in Carolinas where both are based.  The two form a formidable team for the benefit of Rave Group, having worked together before at Bojangles’ restaurants as executives where they both saw the growth of Bojangles in their respective capacities.

    Hill International Inc [NYSE: HIL]

    Hill International Inc is another top performer this morning and is up by over 10% pre-market. The leading managing construction risk company has stated that it has been awarded a contract to provide project management services for the renovation of Kasr al-Ainy Hospitals Development for Cairo University in Egypt. The company is tasked with providing the project management service through the design, procurement, and execution processes. They will also be responsible for building any additional facility buildings if needed.

    Waleed Abdel Fattah, the Senior Vice President of Hill International in North Africa, said in a statement that they are committed to providing efficient services that will see the Iconic Kasr Al-Ainy legacy continues and enable personnel there to provide world-class services. The project, he said will be completed in due time and within the specified budget.

    Ocean Power Technologies Inc [NASDAQ: OPTT]

    This stock is another top performer pre-market and is up by over 37% pre-market. This follows news that the company has entered into an agreement with Aspire Capital Fund and LLC that will see the power technology company sell common stock worth about $12.5 million. This agreement will run for 30 months and will see Ocean Power get funds to purchase more machinery like PowerBuoys to meet potential energy demands.

    The company will also see the advancement of existing projects and initiate new solutions in their bid to provide efficient ocean energy to their clients. The company’s President George H. Kirby said that they are excited about this development that will see them access flexible capital on a cost-effective basis.

  • 3 Potentially Profitable Stocks Today Amidst Mixed Market Sentiment

    3 Potentially Profitable Stocks Today Amidst Mixed Market Sentiment

    Westwater Resources Inc [NASDAQ: WWR]

    Westwater Resources, Inc. has applauded President Trump’s Executive Order that was signed on September 30, 2020, declaring that United States’ reliance of foreign countries for the supply of critical minerals is a threat to the national security. This has seen the stock rally pre-market since the directive favors the company’s projects in the long run, especially on graphite production.

    Following this directive, the President has ordered the relevant departments to accelerate the issuance of permits and finance to companies involved in the mining and supply of the same within the US. These agencies include the Office of Science and Technology, the Secretary of Defense, Secretary of Energy and that of the Interior among others.

    Graphite and vanadium are critical minerals used in the technology industry and are thus a cause of concern to the country were their supply to be curtailed of cut off by foreign suppliers hence the order.

    Xtant Medical Inc [NYSE: XTNT]

    Xtant continues to gain upside momentum days after taking a move to restructure debt. In a move to reduce its outstanding debt, the company stated that it had ended its previously announced debt restructuring transaction. The aim of this transaction was to help improve the company’s capital structure by reducing its total debt. This reduction will enable Xtant access to capital markets and regain the compliance standards of getting listed in the NYSE. The company will now be in a position to get investment to stir up its growth.

    As part of the transaction, Xtant issued about 57.8 million shares of its common stock which they expected to raise about $40.8 million. This amount will represent part of the aggregate outstanding principal amount. There will also be another $21.1 million of outstanding of PIK interest.

    Alteryx Inc [NYSE: AYX]

    Alteryx is gaining quite strongly pre-market after releasing strong Q3 forecast. The company has announced that in the third quarter, it expects revenue ranging from $126 million to $128 million, an improvement from the earlier figures of $111 million to $115 million that they had issued on August 6, 2020.

    Further, Alteryx has announced that Mark Anderson, who is currently a board member, is set to replace current CEO and co-founder Dean Stoecker with immediate effect. Stoecker will now be an executive chairman and the chairman of the company’s board. This further strengthens the company’s future prospects and could see it gain significantly in the short-term.

     

  • 3 High Potential Stock to Watch Today: Biotechs Lead the Way

    MyoKardia Inc [NASDAQ: MYOK]

    In a bid to expand its portfolio of heart drugs, Bristol-Myers Squibb Co. Has agreed with MyoKardia Inc to purchase the company for $13.1 billion. In the agreement, Bristol-Myers is set to pay $225 per share which is about 61% premium over the company’s Friday’s closing stock price. MyoKardia’s stock price had risen 59% in its premarket trading.  Following this purchase, Bristol-Myers will now control MyoKardia’s leading product Mavacamten.

    This experimental drug treats obstructive hypertrophic cardiomyopathy. This acquisition will have expanded Bristol-Myers’ scope of heart drugs from those focussing only on oncology, an area where the industry has focussed on for quite a while now. According to the statement issued regarding this deal, Bristol-Myers will issue an application for the approval of Mavacamten during the first quarter of 2021.

    The company plans to research more on the uses of this drug and manufacture other additional experimental compounds that they will get from MyoKardia. Hypertrophic cardiomyopathy is a heart condition in which heart muscles develop abnormal thickness preventing the heart from pumping blood effectively. The condition affects about one in 500 people.

    Kosmos Energy Ltd [NYSE: KOS]  

    Kosmos Energy, a deepwater independent gas and oil exploration and production company announced today that it has shut down its facility at the Gulf of Mexico with Trafigura Trading LLC and Beal Bank USA.  In a move set to strengthen the corporation’s liquidity position, it has restructured its facility at the Gulf of Mexico into a five-year $200 million loan term that will be backed by the company’s assets at the same Gulf.

    Another $50 million advanced from Trafigura signed in June has been rolled into the facility with backing from CSG Investments; Inc. Beal Bank will provide the remaining $150 million. With a 6% interest rate, the facility has increased its borrowing capacity by $50 million, extended its repayment term by five years, and secured a feature to expand the facility by up to $300 million.

    Neal Shah, the Chief Financial Officer said in a statement that the closing of this facility has enhanced the company’s liquidity position, given it access to low-cost and flexible financing as well as free cash generated low-cost production assets. He expects the company’s balance sheet to strengthen significantly as of 2021.

    Corvus Pharmaceuticals Inc [NASDAQ: CRVS]

    Corvus share price saw a sudden spike after the company announced that its small phase 1 early-stage clinical trial could produce antibodies and T-cells among some Covid-19 patients. The share price rose by 39.1% in premarket trading on Monday after this announcement.

    The clinical trial, open-label, Phase 1 study has already administered three doses in 15 test-patients and hopes to expand its scope to about 30 patients that exhibit mild to moderate symptoms of the disease.  In a preprint issued in September, the company had shown the results for the two of the doses administered in 10 patients. This publication has not been peer-reviewed.

    Corvus plans to release the full results from the first phase at the end of this year.  Its stock is still 25.2% down as of this year with the S&P 500 gaining about 3.6%.

  • 3 Stocks Braving Market Selloff after Trump Tests Positive for COVID-19

    3 Stocks Braving Market Selloff after Trump Tests Positive for COVID-19

    Equity markets have fallen sharply today all over the world. In the U.S, key indices are all in the red pointing to a potentially weak close to the week. In pre-market trading, the NASDAQ is down by 2%, the S&P 500 by 1.55%, and the Dow Jones by 1.46%.

    This follows news that the U.S president had tested positive for COVID-19. The president announced via twitter that together with his wife, they had tested positive for the virus and that they had started quarantine. This has thrown the markets into a spin as it indicates just how serious and unrelenting the virus is. It is also noteworthy that the number of infections continues to rise globally, and some countries have returned to strict lockdown measures shortly after easing them up.

    The number of deaths continues to rise too and recently crossed the one million mark. This points to a prolonged period of a disrupted global economy that could remain unstable until a vaccine is found. The worst part is that the news of the president contracting the virus has come just weeks to an election after a highly emotive campaign. However, even as overall market momentum points to weakness, there are stocks that are braving the selloff and doing quite well. Some of the pre-market gainers that could outperform the market today are as below:

    Nano-X Imaging Ltd [NASDAQ: NNOX]

    Nano-X Imaging Ltd is quite strong pre-market and is up by over 25%. This follows news that the company would do a live demonstration of its new imaging system at the RSNA 2020, between November 29th and December 5th. The company’s demonstration will incorporate a tech section for the company’s first commercial digital X-Ray that would be followed by a demonstration of the system handling both 2D and 3D procedures. The CEO said that they were excited about the demonstration as it exposed the growing depth of the company’s technology.

    Xtant Medical Holdings [NYSE: XTNT]

    Xtant Medical Holdings Inc is another top performer this morning and is up by over 100% in performer this morning.  This follows the company’s announcement that it had completed its debt restructuring process. The company stated that the goal of the restructuring is to cut down on total debt and help the company access the capital markets for future growth.

    Lonestar Resources U.S Inc [NASDAQ: LONE]

    Lonestar Resources U.S Inc is another top gainer today and is up by over 100%. This comes despite a downgrade of the company by Moody’s to D-PD after it filed for bankruptcy.

  • Stocks to Watch as Bulls Take Charge in U.S Equities

    Stocks to Watch as Bulls Take Charge in U.S Equities

    The U.S markets are headed for a good start to the day with the NASDAQ, Dow, and the S&P 500 all in the green in early morning trading.  This is a reflection of the mood across the world where stocks are largely in positive territory today.

    This follows increased optimism for a stimulus package deal for the world’s largest economy. Earlier in September, the Federal Reserve had indicated that a fiscal stimulus package was needed as it had exhausted all monetary policy options for holding the economy together. Despite the improved outlook, investors are still cautious about the impact of COVID-19 on the economy.

    Recently, the number of deaths from the pandemic crossed the 1 million mark. The numbers keep rising too and some countries such as Spain have gone back into lockdown. In the U.S, major corporations such as Disney have announced they are laying off thousands of Staff due to the pandemic.

    The delicate situation is made even more complex by a highly divisive election in just a few weeks. Despite the complexities in the market, there are stocks that are gaining quite strongly and could trade in positive territory all through the day. Some of the stocks to keep an eye on today are as below:

    Enlivex Therapeutics Ltd [NASDAQ: ENLV]

    Enlivex Therapeutics Ltd is a top performer this morning and is up by over 70% pre-market. This follows the company’s announcement that it had got positive results for its COVID-19 treatment called Allocetra in critically ill patients. The trial included 5 people in critical condition who were released after 5.5 days and 8/5 days respectively of using Allocetra. The company also announced that there were no cases of severe side effects related to the use of Allocetra™. The company stated that if the treatment is approved, it would bridge the gap in the treatment of severe and critical COVID-19 patients.

    American Equity Investment Life Holding Company [NYSE: AEL]

    This is another top perfumer this morning and is up by over 50%. This momentum comes just a day after the company announced it had named Graham Day to lead Eagle Life. The company stated that Graham was bringing in two decades of experience in sales leadership to the company. The move has excited the market if the current price action is anything to go by.

    Advanced Emissions Solutions Inc [NASDAQ: ADES]

    Advanced Emissions Solutions Inc is a top performer pre-market and is up by over 40%. This follows the company’s announcement that it had entered into a 15-year activated carbon supply deal with Cabot Corporation.